- SEC pushed the decision on ETH ETF staking and in-kind redemption to June 2025.
- The regulator has met with key players, including BlackRock, regarding the above issues.
The U.S. Securities and Exchange Commission (SEC) has delayed decisions on staking and in-kind redemption for Ethereum [ETH] ETFs (exchange-traded funds).
The agency sought more time on the staking application on two Grayscale spot ETH ETFs. As a result, the deadline has been extended to the 1st of June. The issuer made the application in February.
What’s next for ETH ETFs
Others like Bitwise, VanEck, 21Shares, Fidelity, Invesco Galaxy, and Franklin Templeton had applied for similar staking provisions for their respective ETH ETF products.
As of this writing, only BlackRock has not applied for the same. But Robert Mitchnick, BlackRock’s head of digital assets, had publicly acknowledged the benefit of staking for the products.
The regulator also delayed decisions on in-kind creation and redemption for ETH ETFs and BTC ETFs. In-kind redemption, unlike current cash settlements demanded by Gary Gensler-led SEC, ensures the use of underlying assets like ETH or BTC.
The in-kind method avoids taxable events and enhances liquidity. The regulator pushed the in-kind decision deadline to 3rd June.
That said, the SEC’s crypto task force has held roundtable discussions with key players, including Jito, MultiCoin Capital, and BlackRock, about crypto ETF staking and in-kind redemption.
Source: Coinglass
Meanwhile, the update didn’t spur any change in ETH’s speculative interest. According to Coinglass data, Open Interest (OI) has been on a decline since February, dropping from nearly $26B to below $20 billion.
This meant that the bearish sentiment persisted even after the update.
On the 4-hour price chart, ETH chalked a bearish rising wedge, which could drag it below $1500 again if the pattern is validated. However, reclaiming $1.8K could allow bulls to advance further.
Source: ETH/USDT, TradingView
- SEC pushed the decision on ETH ETF staking and in-kind redemption to June 2025.
- The regulator has met with key players, including BlackRock, regarding the above issues.
The U.S. Securities and Exchange Commission (SEC) has delayed decisions on staking and in-kind redemption for Ethereum [ETH] ETFs (exchange-traded funds).
The agency sought more time on the staking application on two Grayscale spot ETH ETFs. As a result, the deadline has been extended to the 1st of June. The issuer made the application in February.
What’s next for ETH ETFs
Others like Bitwise, VanEck, 21Shares, Fidelity, Invesco Galaxy, and Franklin Templeton had applied for similar staking provisions for their respective ETH ETF products.
As of this writing, only BlackRock has not applied for the same. But Robert Mitchnick, BlackRock’s head of digital assets, had publicly acknowledged the benefit of staking for the products.
The regulator also delayed decisions on in-kind creation and redemption for ETH ETFs and BTC ETFs. In-kind redemption, unlike current cash settlements demanded by Gary Gensler-led SEC, ensures the use of underlying assets like ETH or BTC.
The in-kind method avoids taxable events and enhances liquidity. The regulator pushed the in-kind decision deadline to 3rd June.
That said, the SEC’s crypto task force has held roundtable discussions with key players, including Jito, MultiCoin Capital, and BlackRock, about crypto ETF staking and in-kind redemption.
Source: Coinglass
Meanwhile, the update didn’t spur any change in ETH’s speculative interest. According to Coinglass data, Open Interest (OI) has been on a decline since February, dropping from nearly $26B to below $20 billion.
This meant that the bearish sentiment persisted even after the update.
On the 4-hour price chart, ETH chalked a bearish rising wedge, which could drag it below $1500 again if the pattern is validated. However, reclaiming $1.8K could allow bulls to advance further.
Source: ETH/USDT, TradingView
Запой — состояние, характеризующееся неконтролируемым и продолжительным употреблением алкоголя, что вызывает сильную интоксикацию организма и нарушения в работе жизненно важных органов. При длительном запое организм испытывает колоссальную нагрузку, страдает сердечно-сосудистая система, печень, почки, а нервная система работает на пределе. Одним из наиболее эффективных методов быстрого и безопасного выхода из запоя является капельница. Наркологическая клиника «Анти-Кризис» в Краснодаре оказывает срочную помощь и вывод из запоя за 24 часа, обеспечивая индивидуальный подход, полную анонимность и доступные цены.
Выяснить больше – вызвать капельницу от запоя в краснодаре
clomid for sale in usa can i purchase clomiphene for sale cost of generic clomid online where can i buy cheap clomiphene without prescription how to get generic clomid tablets get cheap clomiphene without a prescription can i purchase generic clomid online
I am in fact delighted to gleam at this blog posts which consists of tons of useful facts, thanks representing providing such data.
More posts like this would add up to the online elbow-room more useful.
order zithromax 500mg online cheap – oral ciplox 500mg order metronidazole online cheap
semaglutide cheap – semaglutide 14mg pills periactin 4 mg without prescription
motilium online – order cyclobenzaprine 15mg pills how to buy cyclobenzaprine
inderal uk – purchase inderal for sale methotrexate 2.5mg canada
augmentin 625mg generic – atbioinfo where to buy ampicillin without a prescription
nexium 40mg sale – https://anexamate.com/ nexium 40mg usa
warfarin online buy – https://coumamide.com/ order hyzaar sale
buy meloxicam online cheap – https://moboxsin.com/ purchase meloxicam for sale
deltasone ca – aprep lson deltasone 10mg pills
mens erection pills – ed solutions buy ed pills cheap
order amoxil generic – how to buy amoxil amoxicillin canada
forcan canada – diflucan drug oral fluconazole
cenforce sale – fast cenforce rs order cenforce 50mg
purchase cialis online cheap – ciltad gn cialis no perscription overnight delivery
ranitidine price – https://aranitidine.com/ cost zantac
cheap cialis for sale – site cialis 20mg side effects